We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Transatlantic Partners to Collaborate on Ready-to-Use Products for Microbiological Diagnostics

By LabMedica International staff writers
Posted on 28 Oct 2013
Print article
A recently announced transatlantic partnership is dedicated to developing, manufacturing, and marketing ready-to-use media products for microbiological diagnostics and research applications.

The French/German company Sartorius Stedim Biotech (Aubagne, France) - a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry - and BD Diagnostics (Franklin Lakes, NJ, USA), a leading global medical technology company, recently announced the formation of a collaborative effort to develop, manufacture, and market various ready-to-use, prefilled media products for detection and diagnosis of microorganisms in clinical and research laboratories.

Sartorius Stedim Biotech manufactures high quality, single-use filter products for concentration of microbial contaminants, and as part of this partnership agreement, BD Diagnostics will fill special Sartorius single-use products with BD's culture media and supply these back to Sartorius as prepackaged products.

In addition, the companies will be exploring options for extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics.

“Through our agreement with BD, we have created an excellent collaboration. BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD’s expertise combined with Sartorius Stedim Biotech’s know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring,” said Dominique Baly, member of the Sartorius group executive committee.

“The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech, and research customers with these unique product offerings,” said Bob Ferguson, vice president and general manager of BD Diagnostics. “By combining Sartorius Stedim Biotech’s bioprocessing and filtration expertise with BD’s microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing.”

Related Links:
Sartorius Stedim Biotech
BD Diagnostics 


Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Rocking Shaker
HumaRock
New
Human Insulin CLIA
Human Insulin CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.